Nulibry 9.5 mg/1
fosdenopterin hydrobromide · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Sentynl Therapeutics, Inc.
Nulibry is a injection, powder, lyophilized, for solution containing fosdenopterin hydrobromide at 9.5 mg/1, taken intravenous. Manufactured by Sentynl Therapeutics, Inc..
Key Facts
- Brand Name
- Nulibry
- Generic Name
- fosdenopterin hydrobromide
- NDC Code (Product)
42358-295- Manufacturer
- Sentynl Therapeutics, Inc.
- Strength
- 9.5 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA214018
- Marketing Start
- 03/30/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Nulibry used for?
Nulibry contains fosdenopterin hydrobromide. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Nulibry a controlled substance?
Nulibry is not classified as a controlled substance by the DEA.
What is the generic name for Nulibry?
The generic name for Nulibry is fosdenopterin hydrobromide. There are no other listed brand versions of fosdenopterin hydrobromide.
What is the NDC code for Nulibry 9.5 mg/1?
The NDC (National Drug Code) for Nulibry 9.5 mg/1 is 42358-295, listed by Sentynl Therapeutics, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)